Cargando…

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

BACKGROUND: Estrogen receptor positive (ER+) breast cancers (BC) are heterogeneous with regard to their clinical behavior and response to therapies. The ER is currently the best predictor of response to the anti-estrogen agent tamoxifen, yet up to 30–40% of ER+BC will relapse despite tamoxifen treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loi, Sherene, Haibe-Kains, Benjamin, Desmedt, Christine, Wirapati, Pratyaksha, Lallemand, Françoise, Tutt, Andrew M, Gillet, Cheryl, Ellis, Paul, Ryder, Kenneth, Reid, James F, Daidone, Maria G, Pierotti, Marco A, Berns, Els MJJ, Jansen, Maurice PHM, Foekens, John A, Delorenzi, Mauro, Bontempi, Gianluca, Piccart, Martine J, Sotiriou, Christos
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423197/ https://www.ncbi.nlm.nih.gov/pubmed/18498629 http://dx.doi.org/10.1186/1471-2164-9-239

Ejemplares similares

A fuzzy gene expression-based computational approach improves breast cancer prognostication
por: Haibe-Kains, Benjamin, et al.
Publicado: (2010)

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
por: Wirapati, Pratyaksha, et al.
Publicado: (2008)

Gene expression profiling in breast cancer challenges the existence of intermediate histological grade
por: Sotiriou, C, et al.
Publicado: (2005)

Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer
por: Loi, Sherene, et al.
Publicado: (2009)

A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?
por: Haibe-Kains, B., et al.
Publicado: (2008)

Multiple-input multiple-output causal strategies for gene selection
por: Bontempi, Gianluca, et al.
Publicado: (2011)

Comparison of prognostic gene expression signatures for breast cancer
por: Haibe-Kains, Benjamin, et al.
Publicado: (2008)

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial
por: Desmedt, Christine, et al.
Publicado: (2009)

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues
por: Toussaint, Jérôme, et al.
Publicado: (2009)

Relationship between estrogen receptor α location and gene induction reveals the importance of downstream sites and cofactors
por: Parisi, Fabio, et al.
Publicado: (2009)

Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
por: Rothé, Françoise, et al.
Publicado: (2011)

Selecting control genes for RT-QPCR using public microarray data
por: Popovici, Vlad, et al.
Publicado: (2009)

Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen
por: Jansen, Maurice P.H.M., et al.
Publicado: (2016)

Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology
por: Fumagalli, Debora, et al.
Publicado: (2014)

Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients
por: Haibe-Kains, B., et al.
Publicado: (2013)

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial
por: Sonnenblick, Amir, et al.
Publicado: (2015)

Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
por: Beelen, Karin, et al.
Publicado: (2014)

Identifying synergistic regulation involving c-Myc and sp1 in human tissues
por: Parisi, Fabio, et al.
Publicado: (2007)

DNA methylation profiling reveals a predominant immune component in breast cancers
por: Dedeurwaerder, Sarah, et al.
Publicado: (2011)

Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer
por: Klijn, JGM, et al.
Publicado: (2005)

A single-array preprocessing method for estimating full-resolution raw copy numbers from all Affymetrix genotyping arrays including GenomeWideSNP 5 & 6
por: Bengtsson, Henrik, et al.
Publicado: (2009)

Relevance of different prior knowledge sources for inferring gene interaction networks
por: Olsen, Catharina, et al.
Publicado: (2014)

Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis
por: Ramirez-Ardila, Diana, et al.
Publicado: (2017)

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
por: Criscitiello, Carmen, et al.
Publicado: (2010)

Study of Meta-analysis strategies for network inference using information-theoretic approaches
por: Pham, Ngoc C., et al.
Publicado: (2017)

Late effects of adjuvant chemotherapy adumbrate dormancy complexity in breast cancer
por: Demicheli, Romano, et al.
Publicado: (2020)

Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays
por: Jose, Vinu, et al.
Publicado: (2018)

Low CD10 mRNA Expression Identifies High-Risk Ductal Carcinoma In Situ (DCIS)
por: Toussaint, Jérôme, et al.
Publicado: (2010)

Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response
por: Li, Qiyuan, et al.
Publicado: (2011)

GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients
por: Piersma, Djura, et al.
Publicado: (2007)

Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome
por: Vuaroqueaux, Vincent, et al.
Publicado: (2007)

Predictive networks: a flexible, open source, web application for integration and analysis of human gene networks
por: Haibe-Kains, Benjamin, et al.
Publicado: (2012)

Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer
por: Sonnenblick, Amir, et al.
Publicado: (2015)

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
por: Li, Yang, et al.
Publicado: (2010)

Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ
por: Germann, Markus, et al.
Publicado: (2019)

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
por: Azim, Hatem A, et al.
Publicado: (2015)

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
por: Maetens, Marion, et al.
Publicado: (2017)

Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue
por: Antonov, Janine, et al.
Publicado: (2010)

Somatic Mutation Profiling and Associations With Prognosis and Trastuzumab Benefit in Early Breast Cancer
por: Loi, Sherene, et al.
Publicado: (2013)

Using shRNA experiments to validate gene regulatory networks
por: Olsen, Catharina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6jibptcte21at1p1gk3bcre2dk